vs
GREEN DOT CORP（GDOT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是GREEN DOT CORP的1.5倍（$772.1M vs $498.6M），Revvity净利率更高（12.7% vs -9.4%，领先22.1%），GREEN DOT CORP同比增速更快（14.3% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-76.3M），过去两年Revvity的营收复合增速更高（9.0% vs 6.5%）
绿点公司是总部位于美国得克萨斯州奥斯汀的金融科技及银行控股公司，按市值计算是全球规模最大的预付借记卡企业，同时经营支付平台业务，为Apple Cash、优步、Intuit提供技术平台支持。公司由史蒂夫·斯特赖特于1999年创立，最初面向青少年推出线上购物预付借记卡，2001年转型服务无银行账户及银行服务不足的群体。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GDOT vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$498.6M
营收增速更快
GDOT
高出8.5%
5.9%
净利率更高
RVTY
高出22.1%
-9.4%
自由现金流更多
RVTY
多$238.1M
$-76.3M
两年增速更快
RVTY
近两年复合增速
6.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $498.6M | $772.1M |
| 净利润 | $-46.8M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | -5.5% | 14.5% |
| 净利率 | -9.4% | 12.7% |
| 营收同比 | 14.3% | 5.9% |
| 净利润同比 | -1017.6% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDOTRVTY
| Q4 25 | $498.6M | $772.1M | ||
| Q3 25 | $472.2M | $698.9M | ||
| Q2 25 | $482.7M | $720.3M | ||
| Q1 25 | $537.2M | $664.8M | ||
| Q4 24 | $436.1M | $729.4M | ||
| Q3 24 | $393.7M | $684.0M | ||
| Q2 24 | $392.5M | $691.7M | ||
| Q1 24 | $439.3M | $649.9M |
净利润GDOTRVTY
| Q4 25 | $-46.8M | $98.4M | ||
| Q3 25 | $-30.8M | $46.7M | ||
| Q2 25 | $-47.0M | $53.9M | ||
| Q1 25 | $25.8M | $42.2M | ||
| Q4 24 | $5.1M | $94.6M | ||
| Q3 24 | $-7.8M | $94.4M | ||
| Q2 24 | $-28.7M | $55.4M | ||
| Q1 24 | $4.8M | $26.0M |
毛利率GDOTRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率GDOTRVTY
| Q4 25 | -5.5% | 14.5% | ||
| Q3 25 | -7.0% | 11.7% | ||
| Q2 25 | 2.8% | 12.6% | ||
| Q1 25 | 11.3% | 10.9% | ||
| Q4 24 | 3.3% | 16.3% | ||
| Q3 24 | -0.7% | 14.3% | ||
| Q2 24 | -6.0% | 12.4% | ||
| Q1 24 | 2.4% | 6.8% |
净利率GDOTRVTY
| Q4 25 | -9.4% | 12.7% | ||
| Q3 25 | -6.5% | 6.7% | ||
| Q2 25 | -9.7% | 7.5% | ||
| Q1 25 | 4.8% | 6.4% | ||
| Q4 24 | 1.2% | 13.0% | ||
| Q3 24 | -2.0% | 13.8% | ||
| Q2 24 | -7.3% | 8.0% | ||
| Q1 24 | 1.1% | 4.0% |
每股收益（稀释后）GDOTRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $890.2M | $7.3B |
| 总资产 | $6.0B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GDOTRVTY
| Q4 25 | $1.4B | $919.9M | ||
| Q3 25 | $1.6B | $931.4M | ||
| Q2 25 | $2.3B | $991.8M | ||
| Q1 25 | $1.8B | $1.1B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.1B | $1.7B |
股东权益GDOTRVTY
| Q4 25 | $890.2M | $7.3B | ||
| Q3 25 | $913.3M | $7.4B | ||
| Q2 25 | $920.9M | $7.6B | ||
| Q1 25 | $947.7M | $7.6B | ||
| Q4 24 | $873.6M | $7.7B | ||
| Q3 24 | $932.2M | $7.9B | ||
| Q2 24 | $870.0M | $7.9B | ||
| Q1 24 | $870.6M | $7.8B |
总资产GDOTRVTY
| Q4 25 | $6.0B | $12.2B | ||
| Q3 25 | $5.8B | $12.1B | ||
| Q2 25 | $5.6B | $12.4B | ||
| Q1 25 | $5.7B | $12.4B | ||
| Q4 24 | $5.4B | $12.4B | ||
| Q3 24 | $5.3B | $12.8B | ||
| Q2 24 | $5.5B | $13.4B | ||
| Q1 24 | $5.3B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-62.5M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-76.3M | $161.8M |
| 自由现金流率自由现金流/营收 | -15.3% | 21.0% |
| 资本支出强度资本支出/营收 | 2.8% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $66.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流GDOTRVTY
| Q4 25 | $-62.5M | $182.0M | ||
| Q3 25 | $23.3M | $138.5M | ||
| Q2 25 | $69.0M | $134.3M | ||
| Q1 25 | $108.7M | $128.2M | ||
| Q4 24 | $-23.0M | $174.2M | ||
| Q3 24 | $-16.3M | $147.9M | ||
| Q2 24 | $31.5M | $158.6M | ||
| Q1 24 | $89.2M | $147.6M |
自由现金流GDOTRVTY
| Q4 25 | $-76.3M | $161.8M | ||
| Q3 25 | $3.5M | $120.0M | ||
| Q2 25 | $49.5M | $115.5M | ||
| Q1 25 | $89.3M | $112.2M | ||
| Q4 24 | $-45.1M | $149.8M | ||
| Q3 24 | $-37.0M | $125.6M | ||
| Q2 24 | $14.5M | $136.6M | ||
| Q1 24 | $74.7M | $129.7M |
自由现金流率GDOTRVTY
| Q4 25 | -15.3% | 21.0% | ||
| Q3 25 | 0.8% | 17.2% | ||
| Q2 25 | 10.3% | 16.0% | ||
| Q1 25 | 16.6% | 16.9% | ||
| Q4 24 | -10.3% | 20.5% | ||
| Q3 24 | -9.4% | 18.4% | ||
| Q2 24 | 3.7% | 19.7% | ||
| Q1 24 | 17.0% | 20.0% |
资本支出强度GDOTRVTY
| Q4 25 | 2.8% | 2.6% | ||
| Q3 25 | 4.2% | 2.6% | ||
| Q2 25 | 4.0% | 2.6% | ||
| Q1 25 | 3.6% | 2.4% | ||
| Q4 24 | 5.1% | 3.4% | ||
| Q3 24 | 5.3% | 3.3% | ||
| Q2 24 | 4.3% | 3.2% | ||
| Q1 24 | 3.3% | 2.7% |
现金转化率GDOTRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 4.22× | 3.03× | ||
| Q4 24 | -4.51× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 18.77× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDOT
| B2B Services | $375.4M | 75% |
| Interchange Revenues | $44.4M | 9% |
| Processing And Settlement Service | $38.6M | 8% |
| Money Movement Services | $37.4M | 8% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
